Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)
Close on Nov 17, 2026Market cap $175.59MP/E –Yield –
Whitehawk Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Whitehawk Therapeutics's ebitda for the twelve months ending Mar 31, 2024 was -$74.44M. For fiscal 2025 it was -$114.32M. The highest annual figure on record is -$2.54M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$114.32M | – |
| FY2024 | Dec 31, 2024 | -$67.27M | – |
| FY2023 | Dec 31, 2023 | -$71.76M | – |
| FY2022 | Dec 31, 2022 | -$62.52M | – |
| FY2021 | Dec 31, 2021 | -$111.11M | – |
| FY2020 | Dec 31, 2020 | -$2.54M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -$19.46M | – |
| Q4 FY2023 | Dec 31, 2023 | -$17.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.81M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.50M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.79M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.43M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.02M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.33M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.74M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.87M | -288.8% |
| Q3 FY2021 | Sep 30, 2021 | -$87.28M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.87M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.09M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.41M | – |
See a number that looks wrong?